Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Consolidated Statements of Cash Flows

v3.24.1.1.u2
Consolidated Statements of Cash Flows
$ in Millions, $ in Millions
12 Months Ended
Mar. 31, 2024
USD ($)
Mar. 31, 2023
USD ($)
Mar. 31, 2022
USD ($)
Cash Flows From Operating Activities      
Net income $ 510.2 $ 512.0 $ 459.1
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization 185.0 172.6 161.8
Lease expense 26.9 23.4 23.2
Deferred income taxes 34.6 48.4 49.8
Stock-based compensation 28.2 15.7 9.0
Asbestos adjustments loss 151.7 37.0 131.7
Excess tax benefits from share-based awards (0.6) (0.2) (2.4)
Gain on sale of land (2.0) (12.7) 0.0
Asset impairment - greenfield site 20.1 0.0 0.0
Other, net 32.2 22.7 17.7
Changes in operating assets and liabilities:      
Accounts and other receivables (19.7) 32.1 (70.9)
Inventories 3.4 (70.8) (64.3)
Operating lease assets and liabilities, net (28.0) (19.0) (19.2)
Prepaid expenses and other assets (21.5) (12.3) (5.7)
Insurance receivable - Asbestos 5.6 6.2 8.3
Accounts payable and accrued liabilities 47.4 (63.2) 136.7
Claims and handling costs paid - Asbestos (116.0) (107.9) (118.8)
Income taxes payable (4.9) 5.5 0.2
Other accrued liabilities 61.6 18.1 41.0
Net cash provided by operating activities 914.2 607.6 757.2
Cash Flows From Investing Activities      
Purchases of property, plant and equipment (449.3) (591.3) (257.8)
Proceeds from sale of property, plant and equipment 4.2 14.1 0.0
Capitalized interest (19.5) (8.5) (1.9)
Purchase of restricted investments - Asbestos (144.2) (180.1) (114.6)
Proceeds from restricted investments - Asbestos 138.3 105.7 26.1
Net cash used in investing activities (470.5) (660.1) (348.2)
Cash Flows From Financing Activities      
Proceeds from term loan 300.0 0.0 0.0
Repayments of term loan (1.9) 0.0 0.0
Proceeds from credit facilities 95.0 450.0 390.0
Repayments of credit facilities (325.0) (260.0) (350.0)
Debt issuance costs (1.2) 0.0 (2.1)
Proceeds from issuance of shares 0.4 0.2 0.3
Repayment of finance lease obligations (1.1) (1.5) (1.0)
Shares repurchased (271.4) (78.4) 0.0
Dividends paid 0.0 (129.6) (484.0)
Taxes paid related to net share settlement of equity awards (4.9) (6.1) (2.8)
Net cash used in financing activities (210.1) (25.4) (449.6)
Effects of exchange rate changes on cash and cash equivalents, restricted cash and restricted cash - Asbestos (3.4) (8.4) (5.9)
Net increase (decrease) in cash and cash equivalents, restricted cash and restricted cash - Asbestos 230.2 (86.3) (46.5)
Cash and cash equivalents, restricted cash and restricted cash - Asbestos at beginning of period 185.6 271.9 318.4
Cash and cash equivalents, restricted cash and restricted cash - Asbestos at end of period 415.8 185.6 271.9
Non-Cash Investing and Financing Activities      
Capital expenditures incurred but not yet paid 75.0 34.7 32.3
Supplemental Disclosure of Cash Flow Activities      
Cash paid for interest 41.8 41.0 37.0
Cash payment for income taxes, net 183.1 117.1 92.7
Cash paid to AICF $ 91.8 $ 109.6 $ 248.5